- Home
- PYPD vs TRAW Comparison
PYPD vs TRAW Comparison
Compare PYPD & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- TRAW
- Stock Information
- Founded
- PYPD 2008
- TRAW 1998
- Country
- PYPD Israel
- TRAW United States
- Employees
- PYPD N/A
- TRAW N/A
- Industry
- PYPD Medical/Dental Instruments
- TRAW
- Sector
- PYPD Health Care
- TRAW
- Exchange
- PYPD Nasdaq
- TRAW NYSE
- Market Cap
- PYPD 16.5M
- TRAW 15.0M
- IPO Year
- PYPD 2020
- TRAW 2013
- Fundamental
- Price
- PYPD $2.93
- TRAW $5.21
- Analyst Decision
- PYPD Strong Buy
- TRAW
- Analyst Count
- PYPD 2
- TRAW 0
- Target Price
- PYPD $12.00
- TRAW N/A
- AVG Volume (30 Days)
- PYPD 28.7K
- TRAW 7.1K
- Earning Date
- PYPD 02-12-2025
- TRAW 11-14-2024
- Dividend Yield
- PYPD N/A
- TRAW N/A
- EPS Growth
- PYPD N/A
- TRAW N/A
- EPS
- PYPD N/A
- TRAW N/A
- Revenue
- PYPD N/A
- TRAW $226,000.00
- Revenue This Year
- PYPD N/A
- TRAW $3.81
- Revenue Next Year
- PYPD N/A
- TRAW N/A
- P/E Ratio
- PYPD N/A
- TRAW N/A
- Revenue Growth
- PYPD N/A
- TRAW N/A
- 52 Week Low
- PYPD $2.37
- TRAW $4.06
- 52 Week High
- PYPD $9.20
- TRAW $27.50
- Technical
- Relative Strength Index (RSI)
- PYPD 33.37
- TRAW 54.54
- Support Level
- PYPD $2.37
- TRAW $4.62
- Resistance Level
- PYPD $3.13
- TRAW $5.19
- Average True Range (ATR)
- PYPD 0.24
- TRAW 0.31
- MACD
- PYPD -0.06
- TRAW 0.04
- Stochastic Oscillator
- PYPD 19.30
- TRAW 70.71
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.